Slow progress. How do we shift the paradigm of thinking in pediatric thrombosis and anticoagulation?

Since Maureen Andrew began systematically describing thrombosis in children in 1994, there has been surprisingly slow process in advancing our knowledge in terms of diagnosis, prevention and treatment of thrombosis in children. There are a variety of reasons for this slow progress. Overwhelmingly the low incidence of thrombosis in children has been a major barrier. Second, the developmental, age related, changes in haemostasis mean that the physiology of haemostasis in children, and the interaction of the haemostatic system with anticoagulant drugs is constantly changing.
Source: Thrombosis Research - Category: Hematology Authors: Tags: Full Length Article Source Type: research